Barclays Increases Globus Medical (NYSE:GMED) Price Target to $103.00
Globus Medical (NYSE:GMED – Free Report) had its target price boosted by Barclays from $100.00 to $103.00 in a report published on Monday,Benzinga reports. They currently have an overweight rating on the medical device company’s stock. GMED has been the subject of a number of other reports. Morgan Stanley raised Globus Medical from an “equal […]
Globus Medical (NYSE:GMED – Free Report) had its target price boosted by Barclays from $100.00 to $103.00 in a report published on Monday,Benzinga reports. They currently have an overweight rating on the medical device company’s stock. GMED has been the subject of a number of other reports. Morgan Stanley raised Globus Medical from an “equal […]
